National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

anti-denatured collagen recombinant monoclonal antibody TRC093
A humanized, affinity-matured IgG1k antibody directed against denatured collagens (I-IV) with potential antiangiogenic and antineoplastic activities. Anti-denatured collagen recombinant monoclonal antibody TRC093 binds to multiple epitopes on denatured collagens, inhibiting proteolytic collagen-mediated signaling in the extracellular matrix (ECM) that is important to tumor angiogenesis, tumor growth, and metastasis. The epitopes on denatured collagen bound by this antibody are considered "cryptic" because, in vivo, they are accessible only on the subendothelial basement membrane of tumors or in normal tissues undergoing neovascularization. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:anti-dn collagen monoclonal antibody TRC093
Code names:D93
TRC093



Previous:anti-CD45 monoclonal antibody, anti-CD45 monoclonal antibody AHN-12, anti-CD70 monoclonal antibody MDX-1411, anti-CEA/anti-DTPA-In (F6-734) bispecific antibody, anti-CS1 monoclonal antibody HuLuc63
Next:anti-EGFRvIII vaccine CDX-110, anti-endoglin monoclonal antibody TRC105, anti-EpCAM antibody fragment -Pseudomonas exotoxin fusion protein, anti-EpCAM antibody fragment-bouganin fusion protein, anti-EpCAM/anti-CD3 recombinant bispecific monoclonal antibody MT110

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov